Skip to main content

Part of the book series: Updates in Surgery ((UPDATESSURG))

  • 801 Accesses

Abstract

Pelvic recurrence of colorectal cancer (PRCRC) is a common problem after curative colorectal resection for colorectal adenocarcinoma, even in the neoadjuvant treatment age, with an incidence varying between 5% and 50% [1, 2]. Although there have been distinct improvements of therapeutic algorithms in managing systemic hepatic and pulmonary colorectal metastasis, there is no general acceptance of the same radical approach for isolated locally recurrent rectal cancer (LRRC) [3, 4]. In the absence of any treatment, survival of patients with PRCRC is poor and is associated with severe and unpleasant symptoms, such as pain, rectal bleeding, bowel or ureter occlusion, tenesmus, enterocutaneous fistulas, and ulcerating skin lesions [1]. Palliative radiotherapy (RT) alone or in combination with chemotherapy can achieve temporary symptomatic improvement in the majority of patients, but 5-year survival is usually <5% [5, 6]. Palliative surgery can prolong survival, but exposes the patient to substantial postoperative morbidity/mortality [5, 6]. Complete surgical resection with clear circumferential and distal margins (R0), in association with multimodal treatment (preoperative radiochemotherapy or intraoperative RT), remains the best option for cure after a PRCRC. The reported 5-year survival rates vary from 22 to 58% after obtaining R0 resection [79]. Therefore, it is essential to: (1) predict failure patterns, and (2) accurately stratify prognosis in relation to the different planned treatments so that appropriate therapy can be selected and proposed. This chapter discusses oncological outcomes of patients with PRCRC resulting from different treatment types.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pacelli F, Tortorelli AP, Rosa F et al (2010) Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Ann Surg Oncol 17:152–162

    Article  PubMed  Google Scholar 

  2. Caricato M, Borzomati D, Ausania F et al (2006) Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol 32:126–132

    Article  CAS  PubMed  Google Scholar 

  3. Hahnloser D, Nelson H, Gunderson LL et al (2003) Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 237:502–508

    PubMed Central  PubMed  Google Scholar 

  4. Hansen MH, Balteskard L, Dørum LM et al (2009) Norwegian Colorectal Cancer Group. Locally recurrent rectal cancer in Norway. Br J Surg 96:1176–1182

    Article  CAS  PubMed  Google Scholar 

  5. Hashiguchi Y, Sekine T, Sakamoto H et al (1999) Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum 42:886–893

    Article  CAS  PubMed  Google Scholar 

  6. Bae SH, Park W, Choi DH et al (2011) Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer. Radiat Oncol 6:52

    Article  PubMed Central  PubMed  Google Scholar 

  7. Bhangu A, Ali SM, Cunningham D et al (2013) Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. Colorectal Dis 15:156–163

    Article  CAS  PubMed  Google Scholar 

  8. Haddock MG, Miller RC, Nelson H et al (2011) Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 79:143–150

    Article  PubMed  Google Scholar 

  9. Larsen SG, Wiig JN, Tretli S et al (2006) Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age. Colorectal Dis 8:177–185

    Article  CAS  PubMed  Google Scholar 

  10. Willett CG, Gunderson LL (2004) Palliative treatment of rectal cancer: is radiotherapy alone a good option? J Gastrointest Surg 8:277-279

    Article  PubMed  Google Scholar 

  11. Lybeert MLM, Martijn H, DeNeve W et al (1992) Radiotherapy for locoregional relapses of rectal carcinoma after initial radical surgery: definite but limited influence of relapse free survival and survival. Int J Radiat Oncol Biol Phys 24:241–246

    Article  CAS  PubMed  Google Scholar 

  12. Guiney MJ, Smith JG, Worotniuk V et al (1997) Radiotherapy treatment for isolated locoregional recurrence of rectosigmoid cancer following definitive surgery: Peter MacCullum Cancer Institute experience, 1981–1990. Int J Radiat Oncol Biol Phys 38:1019–1025

    Article  CAS  PubMed  Google Scholar 

  13. Garcia-Aguilar J, Cromwell JW, Marra C et al (2001) Treatment of locally recurrent rectal cancer. Dis Colon Rectum 44:1743–1748

    Article  CAS  PubMed  Google Scholar 

  14. Asoglu O, Karanlik H, Muslumanoglu M et al (2007) Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 33:1199–1206

    Article  CAS  PubMed  Google Scholar 

  15. Yamada K, Ishizawa T, Niwa K et al (2001) Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 88:988–993

    Article  CAS  PubMed  Google Scholar 

  16. Kanemitsu Y, Hirai T, Komori K et al (2010) Prediction of residual disease or distant metastasis after resection of locally recurrent rectal cancer. Dis Colon Rectum 53:779–789

    Article  PubMed  Google Scholar 

  17. Vermaas M, Ferenschild FT, Nuyttens JJ et al (2005) Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum 48:918–928

    Article  PubMed  Google Scholar 

  18. Weiser MR, Landmann RG, Wong WD et al (2005) Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 48:1169–1175

    Article  PubMed  Google Scholar 

  19. Kakuda JT, Lamont JP, Chu DZ et al (2003) The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg 186:660–664

    Article  PubMed  Google Scholar 

  20. You YN, Habiba H, Chang GJ et al (2011) Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol 18:989–996

    Article  PubMed Central  PubMed  Google Scholar 

  21. Dresen RC, Gosens MJ, Martijn H et al (2008) Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 15:1937–1947

    Article  PubMed Central  PubMed  Google Scholar 

  22. Gagliardi G, Hawley PR, Hershman MJ et al (1995) Prognostic factors in surgery for local recurrence of rectal cancer. Br J Surg 82:1401–1405

    Article  CAS  PubMed  Google Scholar 

  23. Shoup M, Guillem JG, Alektiar KM et al (2002) Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 45:585–592

    Article  PubMed  Google Scholar 

  24. Lopez-Kostner F, Fazio VW, Vignali A et al (2001) Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 44:173–178

    Article  CAS  PubMed  Google Scholar 

  25. Rödel C, Grabenbauer GG, Matzel KE et al (2000) Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 43:312–319

    Article  PubMed  Google Scholar 

  26. Maetani S, Onodera H, Nishikawa T (2007) Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer. Dis Colon Rectum 50:1558–1565

    Article  PubMed  Google Scholar 

  27. Melton GB, Paty PB, Boland PJ et al (2006) Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 49:1099–1107

    Article  PubMed  Google Scholar 

  28. Kusters M, Dresen RC, Martijn H et al (2009) Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys 75:1444–1449

    Article  PubMed  Google Scholar 

  29. Sagar PM, Gonsalves S, Heath RM et al (2009) Composite abdominosacral resection for recurrent rectal cancer. Br J Surg 96:191–196

    Article  CAS  PubMed  Google Scholar 

  30. Reerink O, Mulder NH, Botke G et al (2004) Treatment of locally recurrent rectal cancer, results and prognostic factors. Eur J Surg Oncol 30:954–958

    Article  CAS  PubMed  Google Scholar 

  31. Rahbari NN, Ulrich AB, Bruckner T et al (2011) Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure? Ann Surg 253:522–533

    Article  PubMed  Google Scholar 

  32. Bedrosian I, Giacco G, Pederson L et al (2006) Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 49:175–182

    Article  PubMed  Google Scholar 

  33. Heriot AG, Byrne CM, Lee P et al (2008) Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 51:284–291

    Article  PubMed  Google Scholar 

  34. Saito N, Koda K, Takiguchi N et al (2003) Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 20:192–199

    Article  PubMed  Google Scholar 

  35. Boyle KM, Sagar PM, Chalmers AG et al (2005) Surgery for locally recurrent rectal cancer. Dis Colon Rectum 48:929–937

    Article  PubMed  Google Scholar 

  36. Valentini V, Morganti AG, Gambacorta MA et al (2006) Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys 64:1129–1139

    Article  PubMed  Google Scholar 

  37. Mohiuddin M, Marks G, Marks J (2002) Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 95:1144–1150

    Article  PubMed  Google Scholar 

  38. Wells BJ, Stotland P, Ko MA et al (2007) Results of an aggressive approach to resection of locally recurrent rectal cancer. Ann Surg Oncol 14:390–395

    Article  PubMed  Google Scholar 

  39. Takagi H, Morimoto T, Hara S et al (1986) Seven cases of pelvic exenteration combined with sacral resection for locally recurrent rectal cancer. J Surg Oncol 32:184–188

    Article  CAS  PubMed  Google Scholar 

  40. Pearlman NW, Donohue RE, Stiegmann GV et al (1987) Pelvic and sacropelvic exenteration for locally advanced or recurrent anorectal cancer. Arch Surg 122:537–541

    Article  CAS  PubMed  Google Scholar 

  41. Moriya Y, Akasu T, Fujita S et al (2004) Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 47:2047–2053

    Article  PubMed  Google Scholar 

  42. Lindel K, Willett CG, Shellito PC et al (2001) Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. Radiother Oncol 58:83–87

    Article  CAS  PubMed  Google Scholar 

  43. Mannaerts GH, Rutten HJ, Martijn H et al (2001) Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum 44:1749–1758

    Article  CAS  PubMed  Google Scholar 

  44. Mercantini P, Di Somma S, Magrini L et al (2012) Preoperative brain natriuretic peptide (BNP) is a better predictor of adverse cardiac events compared to preoperative scoring system in patients who underwent abdominal surgery. World J Surg 36:24–30

    Article  PubMed  Google Scholar 

  45. Wiig JN, Tveit KM, Poulsen JP et al (2002) Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 62:207–213

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Filippo La Torre .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Italia

About this chapter

Cite this chapter

La Torre, F., La Torre, M. (2016). Oncological Outcomes. In: Romano, G.M. (eds) Multimodal Treatment of Recurrent Pelvic Colorectal Cancer. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5767-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5767-8_11

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5766-1

  • Online ISBN: 978-88-470-5767-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics